Readmission rates for patients receiving OPAT are reported to be as high as 20%, mostly due to catheter-related problems, adverse drug reactions, or worsening of the primary infection.
MONIQUE R. BIDELL, PHARMD, BCPS
Advertisement
Articles by MONIQUE R. BIDELL, PHARMD, BCPS
Several recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Advertisement
Latest Updated Articles
- Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract Infections
Published: June 21st 2018 | Updated:
- The Early Bird Gets to Stay Home: Early OPAT Follow-Up Reduces 30-Day Readmissions
Published: February 11th 2020 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Practically Expanding AI's role in Infectious Diseases
2
ID Week Brings Education, Networking and Conference Events Altogether Into One Conference
3
Maternal and Infant RSV Immunization Safe, Boosts Antibody Levels Regardless of Sequence
4
HIV Providers: Shortages and Uneven Distribution Across the US
5
